Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer

Lung Cancer

Volumn 18, Issue 1, 1997, Pages 83-94

  Evans, W K ^a   Earle, C C ^a,c   Stewart, D J ^a   Dahrouge, S ^a   Tomiak, E ^a   Goss, G ^a   Logan, D ^a   Goel, R ^a   Gertler, S Z ^a   Dulude, H ^b  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b Bristol Myers Squibb Canada   (Canada)

^c Societe canadienne du cancer   (Canada)

Author keywords

Carboplatin; Chemotherapy; Non small cell lung cancer; Paclitaxel

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL;

EID: 0030738277     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00046-9     Document Type: Article

References (16)

1. DeVita VTJ, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. fourth ed. Philadelphia: J.B. Lippincott Co., 1993.
2. Rowinsky EK, Donehower RC. Drug Therapy: Paclitaxel (Taxol). NEJM 1995;332:1004-14.
3. Murphy WK, Fosella FW, Winn RJ, et al. Phase II study of Taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 1993;85:384-8.
4. Chang AY, Kim K, Glick J, Anderson T, Karp D, Johnson D. Phase II study of Taxol, Merbarone, and Piroxantrone in stage IV non-small-cell lung cancer: the Eastern Cooperative Oncology Group results. J Natl Cancer Inst 1993;85:388-94.
5. Bonomi PD, Finkelstein DM, Ruckdeschel, JC. Combination chemotherapy versus carboplatin or iproplatin followed by combination chemotherapy in stage IV non-small cell lung cancer: An Eastern Cooperative Oncology Group study. In: Bunn PAJ, Canetta R, Ozols RF, editors. Carboplatin (JM-8): Current Perspectives and Future Directions. Philadelphia, PA: Saunders, 1990:307-315.
6. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 1995;13:1860-70.
7. Johnson DH, Paul DM, Hande KR, DeVore RF. Paclitaxel plus carboplatin for advanced lung cancer: preliminary results of a Vanderbilt University phase II trial - LUN-46. Sem Oncol 1995;22:30-3.
8. Johnson D, Paul D, Hande K, et al. Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: A phase II trial. J Clin Oncol 1996;14:2054-60.
9. Calvert AH, Newell DR, Gumbrell LA. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:1748-56.
10. Vafai D, Israel V, Zaretsky S, Natale, RB. Phase I/II trial of combination carboplatin and taxol in non-small cell lung cancer (NSCLC) [abstract 1067]. Proc ASCO 1995;14.
11. Schutte W, Bork I, Sucker S. Phase II trial of paclitaxel and carboplatin as first line treatment in advanced non-small cell lung cancer [abstract 1208]. Proc ASCO 1996;15.
12. Georgiadis M, Schuler B, Johnson B. Four-day Paclitaxel infusion with cisplatin for patients with lung cancer. Sem Oncol 1995;22:67-9.
13. Chang A, Boros L, Garrow G, Asbury R. Paclitaxel by 3-hour infusion followed by 96-hour infusion on failure in patients with refractory malignant disease. Sem Oncol 1995;22:124-7.
14. Eisenhauer E, ten Bokkel Huinink W, Swenerton K. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol 1994;12:2654-66.
15. Hainsworth JD, Thompson DS, Urba WJ, et al. One hour paclitaxel plus carboplatin in advanced non-small cell lung cancer: Preliminary results of a multi-institutional phase II study [abstract 1131]. Proc ASCO 1996;15.
16. Langer C, Kaplan R, Rosvold E, et al. Paclitaxel by 1 hour infusion combined with carboplatin in advanced non-small cell lung carcinoma: A phase II study [abstract 1200], Proc ASCO 1996;15.